Month: February 2018

Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts when compared to fair value? One way to find these companies is by looking at several key metrics and financial ratios, many of which are crucial in the value stock selection process. […]

After several delays and months of negotiations, SeaDrill Limited SDRL recently announced final restructuring agreement on Feb 26, post which shares of the company rose 10.27% to eventually close at 29 cents. However, shares scaled down more than 6.8% to close at 27 cents on Feb 27. Being one of the worst sufferers of the downturn and burdened with massive debt, the company had filed for Chapter 11 bankruptcy protection on Sep 12 to restructure its balance sheet amid volatile oil prices. […]

Community Health Systems, Inc. CYH reported adjusted loss of 25 cents per share in the fourth quarter of 2017, narrower than the Zacks Consensus Estimate of a loss of 36 cents. However, adjusted loss incurred compares unfavorably with adjusted earnings of 46 cents in the year-ago quarter on lower revenues […]

Big 5 Sporting Goods Corporation BGFV posted narrower-than-expected loss in the fourth quarter. However, sales missed the Zacks Consensus Estimate for the third straight quarter. Moreover, results declined year over year […]

Theravance Biopharma TBPH reported fourth-quarter 2017 loss of $1.64 per share, wider than both the Zacks Consensus Estimate of a loss of $1.15 and the year-ago loss of $1.36. Total revenues in the quarter plunged 21.1% year over year to $4.5 million compared with the prior-year figure. […]

Shares of Palo Alto Networks, Inc. PANW rallied to a new 52-week high of $179.15, eventually closing at $173.24 on Feb 27. The momentum can be primarily attributed to impressive second quarter fiscal 2018 results. […]

SandRidge Energy, Inc. SD has recently laid off 80 employees from Oklahoma City, OK office, which is around 30% of its workforce there. Following the job cut, the battery of staff in the office reduced to 189 from 269 […]

Jazz Pharmaceuticals Public Limited Company JAZZ reported fourth-quarter 2017 adjusted earnings of $2.95 per share, marginally missing the Zacks Consensus Estimate of $2.98. However, the bottom line increased 9% from the year-ago figure. Total revenues in the quarter rose 10% year over year to $436.4 million owing to higher sales of the company’s marketed drug, Xyrem, and sales from the launch of Vyxeos in the United States last August. […]

Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts when compared to fair value? One way to find these companies is by looking at several key metrics and financial ratios, many of which are crucial in the value stock selection process […]